Rain Oncology is a clinical-stage company focusing on research and development of innovative therapies for cancer patients. Rain Oncology provides a tumor-agnostic strategy to select patients based on tumorsâ?? underlying genetics rather than histology. Rain Oncology was founded in 2017 and was headquartered in Newark, California.
Sector:
Health Technology
Industry:
Biotechnology
Employees:
N/A
Frequently Asked Questions
What is Market Cap of Rain Oncology Inc?
Market cap, also known as market capitalization, is the total market value of a company. It’s calculated by multiplying the current market price by the total number of shares outstanding. Rain Oncology Inc market cap is $54.67M.
What is the 52-week high for Rain Oncology Inc?
52 week high is the highest price of a stock in the past 52 weeks, or one year. Rain Oncology Inc 52 week high is $11.32 as of September 15, 2025.
What is the 52-week low for Rain Oncology Inc?
52 week low is the lowest price of a stock in the past 52 weeks, or one year. Rain Oncology Inc 52 week low is $0.82 as of September 15, 2025.
What is Rain Oncology Inc stock price today?
Rain Oncology Inc stock price today is $1.21.
What was Rain Oncology Inc stock price yesterday?
Rain Oncology Inc stock price yesterday was $1.23.
What is the PE ratio of Rain Oncology Inc?
The Price-to-Earnings (or P/E) ratio is a commonly used tool for valuing a company. It’s calculated by dividing the current share price by the earnings per share (or EPS). It can also be calculated by dividing the company’s Market Cap by the Net Profit. Rain Oncology Inc’s P/E ratio is -0.59.
What is the Price-to-Book ratio of Rain Oncology Inc?
The Price-to-Book (P/B) ratio is a commonly used tool for valuing a company. It’s calculated by dividing a company’s market capitalization by its book value. Rain Oncology Inc P/B ratio is 0.6519.
What is Rain Oncology Inc's EBITDA?
EBITDA is a widely used measure of corporate profitability. It stands for Earnings before Interest, Taxes, Depreciation, and Amortization. It attempts to reflect the cash profit generated by a company’s operations. Rain Oncology Inc's EBITDA is 0.62.
What is the 50-day moving average of Rain Oncology Inc?
The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. It’s calculated by averaging the closing stock price over the previous 50 trading days. Rain Oncology Inc 50-day moving average is $1.18.
